Amendment to Prime Vendor Agreement Between Standard Management Corporation, ("Customer") and AmerisourceBergen Drug Corporation Dated as of March 1, 2006Prime Vendor Agreement • May 15th, 2006 • Standard Management Corp • Retail-drug stores and proprietary stores
ContractPrime Vendor Agreement • May 5th, 2020
EX-10.4 5 exhibit10-4.htm EXHIBIT 10.4 Exhibit 10.4 PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. THE SYMBOL “[***]” IN THIS EXHIBIT INDICATES THAT INFORMATION HAS BEEN SO OMITTED. PRIME VENDOR AGREEMENT FOR PHARMACEUTICALS THIS AGREEMENT effective as of July 27, 2010 (the “Effective Date”), is between McKesson Corporation (“McKesson” or “MHS”), a Delaware corporation with its principal place of business at One Post Street, San Francisco, California 94104, and Omnicare, Inc. (“Omnicare”), a Delaware corporation with its principal place of business at 1600 RiverCenter 100 East RiverCenter Blvd. Covington, Kentucky 41011. WHEREAS, MHS is engaged in the business of wholesale distribution of pharmaceuticals and the provision of related goods and services. Omnicare is a pharmacy chain which dispenses pharmaceuticals and related goods and services through its long-term care, retail
EX-10.7 2 dex107.htm AMERISOURCEBERGEN PRIME VENDOR AGREEMENT CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT UNDER RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934. THE OMITTED MATERIALS HAVE BEEN...Prime Vendor Agreement • May 5th, 2020 • New York
This Prime Vendor Agreement (“Agreement”) is made as of May 1, 2006 (“Effective Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and NMHCRx Mail Order, Inc., dba NMHC Mail, a Delaware corporation (“Customer”).
EX-10.4 3 dex104.htm FORM OF PRIME VENDOR AGREEMENT [*] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. PRIME VENDOR...Prime Vendor Agreement • May 5th, 2020 • Pennsylvania
This Prime Vendor Agreement for Long-Term Care Pharmacies (“Agreement”) is made as of [ ], 200[ ] (“Effective Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and [ ], a Delaware corporation, on behalf of itself and its wholly owned subsidiaries (“Customer”).
EX-10.5 8 dex105.htm FORM OF PRIME VENDOR AGREEMENT [*] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. PRIME VENDOR...Prime Vendor Agreement • May 5th, 2020 • Pennsylvania
This Prime Vendor Agreement for Long-Term Care Pharmacies (“Agreement”) is made as of [ ], 200[ ] (“Effective Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and [ ], a Delaware corporation, on behalf of itself and its wholly owned subsidiaries (“Customer”).
PRIME VENDOR AGREEMENTPrime Vendor Agreement • July 21st, 2017 • Dougherty's Pharmacy, Inc. • Retail-drug stores and proprietary stores
This Prime Vendor Agreement (the “Agreement”) is made by and between Cardinal Health 110, LLC and Cardinal Health 411, Inc. (“Cardinal Health”) and Dougherty's Holdings, Inc. (“Buyer”), who hereby agree as follows:
EXHIBIT 10.06 [***] indicates the omission of confidential portions for which confidential treatment has been requested. Such confidential information has been filed separately with the Securities and Exchange Commission. SECOND AMENDMENT TO PRIME...Prime Vendor Agreement • November 8th, 2005 • Cardinal Health Inc • Wholesale-drugs, proprietaries & druggists' sundries
EX-10.5 37 dougherty_ex1005.htm AMENDMENT TO PRIME VENDOR AGREEMENT First AMENDMENT TO THE PRIME VENDOR AGREEMENTPrime Vendor Agreement • May 5th, 2020
This First Amendment to the Prime Vendor Agreement (the “First Amendment”) is made and entered into by and between Dougherty's Holdings, Inc. (“Buyer”) and Cardinal Health 110, LLC (f/k/a Cardinal Health 110, Inc.) and Cardinal Health 411, Inc. (collectively referred to herein as “Cardinal Health”).
TO THE PRIME VENDOR AGREEMENTPrime Vendor Agreement • June 2nd, 2017 • Dougherty's Pharmacy, Inc. • Services-business services, nec
This Second Amendment to the Prime Vendor Agreement (the “Second Amendment”) is made and entered into by and between Dougherty's Holdings, Inc. (“Buyer”) and Cardinal Health 110, LLC and Cardinal Health 411, Inc. (collectively referred to herein as “Cardinal Health”).
TO THE PRIME VENDOR AGREEMENTPrime Vendor Agreement • June 2nd, 2017 • Dougherty's Pharmacy, Inc. • Services-business services, nec
This Sixth Amendment to the Prime Vendor Agreement (the “Sixth Amendment”) is made and entered into by and between Dougherty's Holdings, Inc. (“Buyer”) and Cardinal Health 110, LLC and Cardinal Health 112, LLC (collectively referred to herein as “Cardinal Health”).
THIRD AMENDMENT TO PRIME VENDOR AGREEMENTPrime Vendor Agreement • October 6th, 2016 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
This Third Amendment (“Third Amendment”) is made and entered into as of October 1, 2016 (“Third Amendment Effective Date”), by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (“Diplomat”) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy Great Lakes Distribution Center, LLC, Diplomat Specialty Pharmacy of Southern California, LLC, Navigator Pharmacy Service, LLC, Diplomat Specialty Pharmacy of Philadelphia, LLC, Diplomat Specialty Pharmacy of Boothwyn, LLC, and BioRx, LLC (Diplomat and such limited liability companies being referred to herein collectively as “Customer”) on the other hand. This Third Amendment amend
FIRST AMENDMENT TOPrime Vendor Agreement • June 1st, 2006 • Longs Drug Stores Corp • Retail-drug stores and proprietary stores
This is the first amendment (“Amendment”) to the 2006 Prime Vendor Agreement (“2006 Agreement”) dated March 14, 2006 (“Agreement Effective Date”) between AmerisourceBergen Drug Corporation (“ABDC”) and Longs Drug Stores California, Inc. (“Longs”). This Amendment is effective as of April 19, 2006 (“Amendment Effective Date”).
PRIME VENDOR AGREEMENTPrime Vendor Agreement • December 2nd, 2009 • BioScrip, Inc. • Retail-drug stores and proprietary stores • Pennsylvania
This Prime Vendor Agreement ("Agreement") is made as of July 1, 2009 ("Agreement Date") by AmerisourceBergen Drug Corporation, a Delaware corporation ("ABDC"), and BioScrip, Inc., a Delaware corporation, on behalf of itself and its subsidiaries (collectively, "Customer").
AMENDMENT TO PRIME VENDOR AGREEMENTPrime Vendor Agreement • October 28th, 2008 • Assured Pharmacy, Inc. • Retail-drug stores and proprietary stores • Pennsylvania
This Amendment to Prime Vendor Agreement (this “Amendment”) is made as of the 22nd day of October, 2008, by and between AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and Assured Pharmacy, Inc., a Nevada corporation (“Customer” and together with ABDC, the “Parties”).
Cardinal Health Laurel Pharm, LLC. Prime Vendor AgreementPrime Vendor Agreement • October 7th, 2005 • Tandem Health Care, Inc. • Ohio
This Prime Vendor Agreement (the “Agreement”) is made March 15, 2004 between Laurel Pharm, LLC. (“Buyer”) and Cardinal Health* (“Cardinal”), who hereby agree as follows:
PRIME VENDOR AGREEMENT FOR LONG-TERM CARE PHARMACIESPrime Vendor Agreement • November 9th, 2007 • PharMerica CORP • Retail-drug stores and proprietary stores • Pennsylvania
This Prime Vendor Agreement for Long-Term Care Pharmacies (“Agreement”) is made as of August 1, 2007 (“Effective Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and PharMerica Corporation, a Delaware corporation, on behalf of itself and its wholly owned subsidiaries (“Customer”).
Amendment to Prime Vendor AgreementPrime Vendor Agreement • November 1st, 2007 • Paramount Acquisition Corp • Blank checks
This is the first amendment (the “Amendment”) to the Prime Vendor Agreement (“Agreement”), dated May 1, 2007 (“Agreement Date”), among AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and BJK, Inc., d.b.a. Chem Rx, a New York corporation (“Customer”), Chem Rx New Jersey, LLC, A New Jersey corporation and ChemRx/Salerno’s, LLC, a Pennsylvania limited liability company (“Affiliates”). This Amendment is effective as of October 26, 2007 (“Effective Date”).
First Amendment to Prime Vendor AgreementPrime Vendor Agreement • August 19th, 2014 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
This First Amendment (“Amendment”) is entered into as of July 20, 2012 (“Effective Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (“Diplomat”) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Grand Rapids, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft, Lauderdale, LLC, Diplomat Specialty Pharmacy of Swartz Creek, LLC and Diplomat Specialty Pharmacy of Southern California, LLC (Diplomat and such limited liability companies being referred to herein collectively as “Customer”) on the other hand. This Amendment amends the parties Prime Vendor Agreement dated January 1, 2012 (“PVA”). Capitalized terms not defined in this Amendment have the meaning set forth in th
AMENDED AND RESTATED PRIME VENDOR AGREEMENT FOR LONG-TERM CARE PHARMACIESPrime Vendor Agreement • May 25th, 2011 • PharMerica CORP • Retail-drug stores and proprietary stores • Pennsylvania
This Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies (“Agreement”) is made as of January 1, 2011 (“Effective Date”) by and between AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), on the one hand, and PharMerica Corporation (“PMC”), a Delaware corporation; Pharmacy Corporation of America (“PCA”), a Delaware corporation; and Chem Rx Pharmacy Services, LLC, a Delaware limited liability company (“Chem Rx”), on the other. (Collectively, PMC, PCA and Chem Rx are sometimes referred to hereafter as “Customer”.)
ContractPrime Vendor Agreement • August 3rd, 2010 • BioScrip, Inc. • Retail-drug stores and proprietary stores • New York
Note: Certain material has been omitted from this Second Amendment to Prime Vendor Agreement in accordance with a request for confidential treatment submitted to the Securities and Exchange Commission. [*****] indicates omitted material. The omitted material has been filed separately with the Securities and Exchange Commission.
PRIME VENDOR AGREEMENTPrime Vendor Agreement • May 7th, 2015 • PharMerica CORP • Retail-drug stores and proprietary stores
This Prime Vendor Agreement (the “Agreement”) is effective April 1, 2015 (the “Effective Date”) between PharMerica Corporation located at 1901 Campus Place, Louisville, Kentucky 40299 (“you”, “your” or “Customer”) and Cardinal Health 110, LLC and Cardinal Health 411, Inc., 7000 Cardinal Place, Dublin Ohio 43017 (collectively, “we“, “us” or “our” or “Cardinal Health”), who agree as follows:
PRIME VENDOR AGREEMENTPrime Vendor Agreement • October 9th, 2008 • Assured Pharmacy, Inc. • Retail-drug stores and proprietary stores • Pennsylvania
This Prime Vendor Agreement ("Agreement") is made as of July 1, 2008 ("Effective Date") by AmerisourceBergen Drug Corporation, a Delaware corporation ("ABDC"), and Assured Pharmacy, Inc., a Nevada corporation ("Customer").
AMENDED AND RESTATED PRIME VENDOR AGREEMENTPrime Vendor Agreement • July 21st, 2016 • Tabula Rasa HealthCare, Inc. • Services-business services, nec
This Prime Vendor Agreement (“PVA”) is dated May 1, 2016 (“Effective Date”) between AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and CareKinesis, Inc., a Delaware corporation, and J.A. Robertson, Inc., a California corporation d/b/a St. Mary (collectively, “Customer”).
Cardinal Health 110, LLC, Cardinal Health 411, Inc. and Fred’s Stores of Tennessee, Inc. Prime Vendor AgreementPrime Vendor Agreement • September 11th, 2014 • Freds Inc • Retail-variety stores
This Prime Vendor Agreement (the “Agreement”) is made by and between Cardinal Health 110, LLC and Cardinal Health 411, Inc. (“Cardinal Health”) and Fred’s Stores of Tennessee, Inc. (“Buyer”) who hereby agree as follows:
SIXTH AMENDMENT TO PRIME VENDOR AGREEMENTPrime Vendor Agreement • March 1st, 2018 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
This Sixth Amendment (“Sixth Amendment”) is made and entered into as of October 24, 2017 (“Sixth Amendment Effective Date”), by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (“Diplomat”) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy Great Lakes Distribution Center, LLC, Diplomat Specialty Pharmacy of Southern California, LLC, Navigator Pharmacy Service, LLC, Diplomat Specialty Pharmacy of Philadelphia, LLC, Diplomat Specialty Pharmacy of Boothwyn, LLC, BioRx, LLC, Valley Campus Pharmacy, Inc. d/b/a TNH Specialty Pharmacy, Affinity Biotech, Inc., At-Home IV Infusion Professional Inc., XAS Infusion Suites Inc.,
PRIME VENDOR AGREEMENT By and Between AmerisourceBergen Drug Corporation, a Delaware corporation And Longs Drug Stores California, Inc., a California corporationPrime Vendor Agreement • June 1st, 2006 • Longs Drug Stores Corp • Retail-drug stores and proprietary stores • California
This Prime Vendor Agreement (“Agreement”) is made as of March 14, 2006 (“Execution Date”) by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), and Longs Drug Stores California, Inc., a California corporation (“Longs”).
price advantages and ordering efficiency for customers.Prime Vendor Agreement • October 8th, 2012
All contract dollar values are the best current estimates. For those original contracts that have expired, a “bridge con- tract” was awarded to sustain customer food support while new follow-on solicitations and proposal evaluations are underway.
SECOND AMENDMENT TO PRIME VENDOR AGREEMENTPrime Vendor Agreement • September 15th, 2015 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
This Second Amendment (“Second Amendment”) is made and entered into as of August 1, 2015 (“Second Amendment Effective Date”), by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (“Diplomat”) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy Great Lakes Distribution Center, LLC, Diplomat Specialty Pharmacy of Southern California, LLC, and Navigator Pharmacy Service, LLC (Diplomat and such limited liability companies being referred to herein collectively as “Customer”) on the other hand. This Second Amendment amends the parties Prime Vendor Agreement (“PVA”) dated January 1, 2012, as previously amended on July 20, 201
ContractPrime Vendor Agreement • May 2nd, 2011 • BioScrip, Inc. • Retail-drug stores and proprietary stores • New York
Note: Certain material has been omitted from this Third Amendment to Prime Vendor Agreement in accordance with a request for confidential treatment submitted to the Securities and Exchange Commission. [*****] indicates omitted material. The omitted material has been filed separately with the Securities and Exchange Commission.
FOURTH AMENDMENT TO PRIME VENDOR AGREEMENTPrime Vendor Agreement • November 6th, 2017 • Diplomat Pharmacy, Inc. • Retail-drug stores and proprietary stores
This Fourth Amendment (“Fourth Amendment”) is made and entered into as of May 8, 2017 (“Fourth Amendment Effective Date”), by AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”) on the one hand, and Diplomat Pharmacy, Inc., a Michigan corporation (“Diplomat”) for itself and on behalf of the following limited liability companies of which Diplomat is the sole member: Diplomat Specialty Pharmacy of Flint, LLC, Navigator Health Services, LLC, Diplomat Health Services, LLC, Diplomat Specialty Pharmacy of Chicago, LLC, Diplomat Specialty Pharmacy of Ft. Lauderdale, LLC, Diplomat Specialty Pharmacy Great Lakes Distribution Center, LLC, Diplomat Specialty Pharmacy of Southern California, LLC, Navigator Pharmacy Service, LLC, Diplomat Specialty Pharmacy of Philadelphia, LLC, Diplomat Specialty Pharmacy of Boothwyn, LLC, BioRx, LLC and Valley Campus Pharmacy, Inc. d/b/a TNH Specialty Pharmacy (Diplomat and such limited liability companies being referred to herein collectively as
TO THE PRIME VENDOR AGREEMENTPrime Vendor Agreement • June 2nd, 2017 • Dougherty's Pharmacy, Inc. • Services-business services, nec
This Third Amendment to the Prime Vendor Agreement (the “Third Amendment”) is made and entered into by and between Dougherty's Holdings, Inc. (“Buyer”) and Cardinal Health 110, LLC, Cardinal Health 411, Inc. and Cardinal Health 112, LLC (collectively referred to herein as “Cardinal Health”).
Pharmacy Services Prime Vendor Agreement For Allscripts Healthcare Solutions, Inc. Submitted by: Bergen Brunswig Drug Company (d.b.a. AmerisourceBergen) February 1, 2002Prime Vendor Agreement • May 15th, 2002 • Allscripts Healthcare Solutions Inc • Wholesale-drugs, proprietaries & druggists' sundries
FIFTH AMENDMENT TO PRIME VENDOR AGREEMENTPrime Vendor Agreement • January 26th, 2012 • BioScrip, Inc. • Retail-drug stores and proprietary stores
FIFTH AMENDMENT, dated as of January 1, 2012 (“Fifth Amendment”) to the PRIME VENDOR AGREEMENT made as of July 1, 2009, as amended as of March 2010, June 1, 2010, August 1, 2010 and May 1, 2011 (the “Existing PVA”), between AmerisourceBergen Drug Corporation (“ABDC”), on the one hand, and Bioscrip, Inc., BioScrip Infusion Services, Inc., Chonimed LLC, Bioscrip Pharmacy Inc., Bradhurst Specialty Pharmacy, Inc., Bioscrip Pharmacy (NY), Inc., Bioscrip PBM Services, LLC, Natural Living Inc., Bioscrip Infusion Services, LLC, Bioscrip Nursing Services, LLC, Bioscrip Infusion Management, LLC, Bioscrip Pharmacy Services, Inc., Critical Homecare Solutions, Inc., Specialty Pharma, Inc, New England Home Therapies, Inc., Deaconess Enterprises, LLC, Infusion Solutions, Inc, Professional Home Care Services, Inc., Wilcox Medical, Inc., Deaconess Homecare, LLC, South Mississippi Home Health, Inc., Regional Ambulatory Diagnostics, Inc., Elk Valley Professional Affiliates, Inc., Infusion Partners, LLC,
AMENDED AND RESTATED PRIME VENDOR AGREEMENT FOR LONG-TERM CARE PHARMACIESPrime Vendor Agreement • February 24th, 2011 • PharMerica CORP • Retail-drug stores and proprietary stores • Pennsylvania
This Amended and Restated Prime Vendor Agreement for Long-Term Care Pharmacies (“Agreement”) is made as of January 1, 2011 (“Effective Date”) by and between AmerisourceBergen Drug Corporation, a Delaware corporation (“ABDC”), on the one hand, and PharMerica Corporation (“PMC”), a Delaware corporation; Pharmacy Corporation of America (“PCA”), a Delaware corporation; and Chem Rx Pharmacy Services, LLC, a Delaware limited liability company (“Chem Rx”), on the other. (Collectively, PMC, PCA and Chem Rx are sometimes referred to hereafter as “Customer”.)
TO THE PRIME VENDOR AGREEMENTPrime Vendor Agreement • June 2nd, 2017 • Dougherty's Pharmacy, Inc. • Services-business services, nec
This Fifth Amendment to the Prime Vendor Agreement (the “Fifth Amendment”) is made and entered into by and between Dougherty's Holdings, Inc. (“Buyer”) and Cardinal Health 110, LLC and Cardinal Health 112, LLC (collectively referred to herein as “Cardinal Health”).
